decisionhealth Newsletters, Part B News - 2010 Issue 9 (September)
CMS: It's OK to report e-prescribed narcotics when you meet DEA rules
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS guidance on electronic prescribing reporting for eligible professionals, with attention to controlled substances, DEA rule requirements, and the incentive and penalty timelines tied to the e-prescribing program. It is relevant to physicians, eligible professionals, compliance staff, and coding/billing teams tracking Medicare reporting obligations and program participation. The discussion focuses on the general reporting framework, related federal agency guidance, and the reporting years that affect payment adjustments.
Why This Topic Matters
It helps practices understand how e-prescribing activity may factor into Medicare incentive reporting and later payment adjustments, especially when controlled substances are prescribed electronically under applicable DEA rules.
What You Will Learn
- How CMS ties electronic prescribing activity to its incentive program
- What general DEA requirements are discussed for controlled-substance e-prescribing
- How reporting years relate to future Medicare payment adjustments
- Which types of practitioners and billing teams may need to track this guidance
Who Should Read This
- Physicians
- Eligible professionals
- Medical coders
- Billing staff
- Compliance staff
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com